|Bid||0.00 x 18800|
|Ask||0.00 x 13500|
|Day's Range||473.50 - 488.50|
|52 Week Range||254.00 - 496.50|
|Beta (5Y Monthly)||0.31|
|PE Ratio (TTM)||146.42|
|Earnings Date||Oct 20, 2021|
|Forward Dividend & Yield||0.70 (0.14%)|
|Ex-Dividend Date||Mar 29, 2021|
|1y Target Est||N/A|
SARTORIUS AG (SARTF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
SARTORIUS AG (SARTF) delivered earnings and revenue surprises of 10.45% and 5.63%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
The life science Group Sartorius has continued on its fast growth trajectory, closing the first half of 2021 with significant double-digit increases in both sales revenue and order intake1.